skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 613  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?
Material Type:
Article
Add to My Research

Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?

Journal of the American College of Cardiology, 2015-06, Vol.65 (24), p.2638-2651 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2015 American College of Cardiology Foundation ;Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 23, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.05.001 ;PMID: 26088304

Full text available

2
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

3
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
Material Type:
Article
Add to My Research

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

The Lancet (British edition), 2014-08, Vol.384 (9943), p.599-606 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61216-2 ;PMID: 25131979 ;CODEN: LANCAO

Full text available

4
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

The New England journal of medicine, 2015-04, Vol.372 (16), p.1500-1509 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1500858 ;PMID: 25773607

Full text available

5
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Material Type:
Article
Add to My Research

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

The New England journal of medicine, 2022-11, Vol.387 (20), p.1855-1864 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2211023 ;PMID: 36342163

Full text available

6
Cognitive Function in a Randomized Trial of Evolocumab
Material Type:
Article
Add to My Research

Cognitive Function in a Randomized Trial of Evolocumab

The New England journal of medicine, 2017-08, Vol.377 (7), p.633-643 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1701131 ;PMID: 28813214

Full text available

7
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Circulation (New York, N.Y.), 2019-05, Vol.139 (22), p.2528-2536 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.040130 ;PMID: 30882238

Full text available

8
Inflammatory and Cholesterol Risk in the FOURIER Trial
Material Type:
Article
Add to My Research

Inflammatory and Cholesterol Risk in the FOURIER Trial

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.131-140 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034032 ;PMID: 29530884

Full text available

9
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
Material Type:
Article
Add to My Research

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

Journal of the American College of Cardiology, 2014-12, Vol.64 (24), p.2645-2687 [Peer Reviewed Journal]

American Heart Association, Inc., and the American College of Cardiology Foundation ;2014 American Heart Association, Inc., and the American College of Cardiology Foundation ;2015 INIST-CNRS ;Copyright Elsevier Limited Dec 23, 2014 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2014.09.016 ;CODEN: JACCDI

Full text available

10
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
Material Type:
Article
Add to My Research

Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

European heart journal, 2021-09, Vol.42 (36), p.3727-3738 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab560 ;PMID: 34448003

Full text available

11
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)
Material Type:
Article
Add to My Research

Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)

The American heart journal, 2022-09, Vol.251, p.61-69 [Peer Reviewed Journal]

2022 The Authors ;2022. The Authors ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.05.004

Full text available

12
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.2961-2970 [Peer Reviewed Journal]

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;2019. American College of Cardiology Foundation ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.513 ;PMID: 31196453

Full text available

13
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Material Type:
Article
Add to My Research

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

European heart journal, 2020-07, Vol.41 (25), p.2379-2392 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa183 ;PMID: 32221582

Full text available

14
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
Material Type:
Article
Add to My Research

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

The Lancet (British edition), 2010-10, Vol.376 (9749), p.1312-1319 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 16-Oct 22, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61273-1 ;PMID: 20801494 ;CODEN: LANCAO

Full text available

15
The China Acute Myocardial Infarction (CAMI) Registry: A National Long-term Registry-Research-Education Integrated Platform for Exploring Acute Myocardial Infarction in China
Material Type:
Article
Add to My Research

The China Acute Myocardial Infarction (CAMI) Registry: A National Long-term Registry-Research-Education Integrated Platform for Exploring Acute Myocardial Infarction in China

The American heart journal, 2016-05, Vol.175, p.193-201.e3 [Peer Reviewed Journal]

2015 The Authors ;Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.04.014 ;PMID: 27179740 ;CODEN: AHJOA2

Full text available

16
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role[S]
Material Type:
Article
Add to My Research

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role[S]

Journal of lipid research, 2016-06, Vol.57 (6), p.1086-1096 [Peer Reviewed Journal]

2016 © 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc. ;Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc. 2016 ;ISSN: 0022-2275 ;EISSN: 1539-7262 ;DOI: 10.1194/jlr.P065334 ;PMID: 27102113

Full text available

17
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Material Type:
Article
Add to My Research

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

The American heart journal, 2016-03, Vol.173, p.94-101 [Peer Reviewed Journal]

Mosby, Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.11.015 ;PMID: 26920601

Full text available

18
Myocardial infarction accelerates atherosclerosis
Material Type:
Article
Add to My Research

Myocardial infarction accelerates atherosclerosis

Nature (London), 2012-07, Vol.487 (7407), p.325-329 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Jul 19, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature11260 ;PMID: 22763456 ;CODEN: NATUAS

Full text available

19
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
Material Type:
Article
Add to My Research

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Journal of the American College of Cardiology, 2014-04, Vol.63 (13), p.1278-1288 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2014 American College of Cardiology Foundation ;Copyright Elsevier Limited Apr 8, 2014 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2014.01.006

Full text available

20
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
Material Type:
Article
Add to My Research

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

The American heart journal, 2018-06, Vol.200, p.83-89 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2018.01.012 ;PMID: 29898853

Full text available

Results 1 - 20 of 613  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (565)

Refine My Results

Creation Date 

From To
  1. Before 2002  (13)
  2. 2002 To 2006  (79)
  3. 2007 To 2011  (119)
  4. 2012 To 2017  (141)
  5. After 2017  (262)
  6. More options open sub menu

Language 

  1. English  (612)
  2. Japanese  (53)
  3. Russian  (2)
  4. Norwegian  (2)
  5. More options open sub menu

Searching Remote Databases, Please Wait